Ghent University Academic Bibliography

Your filters: cql: author="Daizadeh, Nadia" or (type any "bookEditor issueEditor" and editor="Daizadeh, Nadia")

Add to list
- Journal Article
- A1
- open access
Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Chien‐Chia Chuang, Isabelle Guillemin, Claus Bachert (UGent) , Stella E. Lee, Peter Hellings (UGent) , Wytske J. Fokkens, Nicolas Duverger, Chunpeng Fan, Nadia Daizadeh, Nikhil Amin, et al.

(2022) LARYNGOSCOPE. 132(2). p.259-264
Add to list
- Journal Article
- A1
- open access
Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert (UGent) , Leda P. Mannent, G. Walter Canonica, Joseph K. Han, Jorge F. Maspero, Cesar Picado, Nadia Daizadeh, Benjamin Ortiz, et al.

(2022) ALLERGY. 77(4). p.1231-1244
Add to list
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Joaquim Mullol, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter W Hellings, Joseph K Han, Roger Jankowski, Jan Vodicka, Philippe Gevaert (UGent) , Nadia Daizadeh, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(4). p.1086-1095.e5
Add to list
- Journal Article
- A1
- open access
Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

G Walter Canonica, Arnaud Bourdin, Anju T Peters, Martin Desrosiers, Claus Bachert (UGent) , Stephan Weidinger, Eric L Simpson, Nadia Daizadeh, Zhen Chen, Siddesh Kamat, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(6). p.1515-1526
Add to list
- Conference Paper
- C3
Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma

Lawrence Sher, Giovanni Passalacqua, Camille Taillé, Lauren Cohn, Santiago Quirce, Nadia Daizadeh, Nami Pandit-Abid, Benjamin Ortiz, Asif H. Khan and Yi Zhang

(2021) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 58(supplement 65).
Add to list
- Conference Paper
- C3
Effect of dupilumab on improving physical activity in patients with severe asthma

Lawrence Sher, Santiago Quirce, Giovanni Passalacqua, Camille Taillé, Lauren Cohn, Nadia Daizadeh, Nami Pandit-Abid, Benjamin Ortiz, Asif H. Khan and Yi Zhang

(2021) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 58(supplement 65).
Add to list
- Conference Paper
- C3
Dupilumab treatment leads to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflafmmation

Ian Pavord, William Busse, Elliot Israel, Stanley Szefler, Zhen Chen, Nadia Daizadeh, David Lederer, Leda Mannent, Nikhil Amin, Elizabeth Laws, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(supplement 2). p.AB4-AB4
Add to list
- Conference Paper
- C3
Effect of Dupilumab on patient-reported breathing and rescue medication use

Jonathan Corren, Mario Castro, Jorge F Maspero, William W Busse, Antonio Valero Santiago, Piotr Kuna, Nadia Daizadeh, Nami Pandit-Abid, Benjamin Ortiz, Asif H. Khan, et al.

(2020) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 56(supplement 64).
Add to list
- Conference Paper
- C3
- open access
Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma : SINUS-52 trial

Claus Bachert (UGent) , Joaquim Mullol, Nadia Daizadeh, Kelley Wolfe, Benjamin Ortiz, Robert Johnson, Yamo Deniz, Paul Rowe, Leda Mannent, Nikhil Amin, et al.

(2020) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 56(64).
Add to list
- Conference Paper
- C3
Dupilumab improves patient-reported breathing in oral corticosteroid-dependent severe asthma

Lawrence Sher, Robert Wolfe, Santiago Quirce, Lauren Cohn, Giovanni Passalacqua, Pierluigi Paggiaro, Camille Taillé, Nadia Daizadeh, Benjamin Ortiz, Nami Pandit-Abid, et al.

(2020) CHEST. 158(4). p.A1752-A1754

Academic Bibliography

Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials

Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma

Effect of dupilumab on improving physical activity in patients with severe asthma

Dupilumab treatment leads to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflafmmation

Effect of Dupilumab on patient-reported breathing and rescue medication use

Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma : SINUS-52 trial

Dupilumab improves patient-reported breathing in oral corticosteroid-dependent severe asthma

Contents

Support

Contact